Myocardial Stiffness Evaluation in Patients With Heart Failure With Preserved Ejection Fraction
Recruiting
Observational Study
Heart Failure With Preserved Ejection Fraction
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 80
- Sex
- Any
- Study type
- Observational
- Participants needed
- 438 (estimated)
- Sponsor
- Haiyan Wang · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this observational study is to evaluating myocardial stiffness in patients with heart failure with preserved ejection fraction (HFpEF) by intrinsic wave velocity propagation (IVP). The main questions it aims to answer are:
* Whether myocardial stiffness assessed by IVP in patients with HFpEF Increased.
* Whether IVP is related to the cardiac structure and function in patients with HFp…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
Meet the diagnostic criteria for HFpEF in the 2022 AHA/ACC/HFSA Guidelines for Heart Failure Management:
* Present with signs and symptoms of heart failure;
* LVEF≥50%;
* There is at least one additional criterion: Increased BNP (BNP≥35pg/ml, NT-pro BNP\>125pg/ml) and resting e…
Contacts